Wow, that's a bit rough Gamgood. While I never deified DR the way some here idolized him at every turn, I could see his game plan and I concurred with it. Like DR, I thought getting FDA approval would be enough- LTC would sell itself because of the amazing contrast with current suturing technologies.
That said, the deals he cut did indeed suck....except for Empire....which IPO never happened. But Cornell, Banco, La Jolla.....hard to justify those deals IMO. He owned tons here....more than the new guy ever will I believe, and he guarded those shares like few CEOs on the OTC or any exchange. But it's a bottom line assessment that a business is judged by, and on that account, well, we all know the current PPS
